We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+101.42%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$669M
AUM Growth
+$482M
Cap. Flow
+$394M
Cap. Flow %
58.85%
Top 10 Hldgs %
31.65%
Holding
214
New
153
Increased
2
Reduced
1
Closed
16

Top Buys

Rank Stock Value
1
NKLA
Nikola Corporation Common Stock
NKLA
+$32.1M
2
TMUS icon
T-Mobile US
TMUS
+$29.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$22.7M
4
DKNG icon
DraftKings
DKNG
+$17.3M
5
PCG icon
PG&E
PCG
+$12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$127M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$17.7M
3
FEAC.U
Flying Eagle Acquisition Corp. Units, each consisting of one share of Class A common stock and one-f
FEAC.U
+$5.98M
4
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
+$5M
5
ADC icon
Agree Realty
ADC
+$2.17M

Sector Composition

Rank Sector Weight
1 Healthcare 32.46%
2 Consumer Discretionary 19.77%
3 Communication Services 8.34%
4 Technology 8.26%
5 Financials 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
126
Pliant Therapeutics
PLRX
$64.4M
$1.17M 0.17%
+36,000
New +$955K
RNAM
127
DELISTED
Avidity Biosciences
RNAM
$1.13M 0.17%
+40,000
New +$1.15M
KLDO
128
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$1.11M 0.17%
+150,000
New +$1.01M
ACEL icon
129
Accel Entertainment
ACEL
$978M
$1.04M 0.16%
107,748
– –
UWMC icon
130
UWM Holdings
UWMC
$461M
$1.01M 0.15%
99,996
– –
GIK.U
131
DELISTED
GigCapital3, Inc. Units, each consisting of one share of Common Stock and three-fourths of one Redee
GIK.U
$1M 0.15%
+100,000
New +$993K
SCVX
132
DELISTED
SCVX Corp.
SCVX
$996K 0.15%
100,000
– –
XERS icon
133
Xeris Biopharma Holdings
XERS
$1.46B
$931K 0.14%
+350,000
New +$1.22M
ROAD icon
134
Construction Partners
ROAD
$6.84B
$888K 0.13%
+50,000
New +$853K
FUSN
135
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$874K 0.13%
+50,000
New +$871K
GBIO
136
DELISTED
Generation Bio
GBIO
$840K 0.13%
+4,000
New +$891K
GTM
137
ZoomInfo Technologies
GTM
$1.25B
$829K 0.12%
+16,237
New +$776K
BNR
138
Burning Rock Biotech
BNR
$115M
$810K 0.12%
+3,000
New +$822K
OPTU
139
Optimum Communications Inc
OPTU
$301M
$789K 0.12%
+35,000
New +$858K
AKUS
140
DELISTED
Akouos Inc
AKUS
$788K 0.12%
+35,000
New +$780K
KZR
141
DELISTED
Kezar Life Sciences
KZR
$777K 0.12%
+15,000
New +$757K
NIO icon
142
NIO
NIO
$11.9B
$772K 0.12%
+100,000
New +$440K
ISEE
143
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$765K 0.11%
+150,000
New +$625K
STLN
144
Starling Oncology, Inc. Common Stock
STLN
$618M
$754K 0.11%
+74,996
New +$746K
DNTH icon
145
Dianthus Therapeutics
DNTH
$6.09B
$751K 0.11%
+6,250
New +$881K
SWAV
146
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$711K 0.11%
+15,000
New +$618K
GMDA
147
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$683K 0.1%
+149,459
New +$686K
IRNT
148
DELISTED
IronNet, Inc.
IRNT
$674K 0.1%
67,968
– –
FREEW
149
DELISTED
Whole Earth Brands, Inc. Warrant
FREEW
$664K 0.1%
+582,406
New +$745K
KLR
150
DELISTED
Kaleyra, Inc.
KLR
$646K 0.1%
+45,714
New +$1.02M
4 5
6
7 8

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Monashee Investment Management held 214 positions worth $669M, up 258% from $187M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Monashee Investment Management deployed $394M of net new capital in Q2 2020, opening 153 new positions and adding to 2 existing holdings. Its largest new stake was Nikola Corporation Common Stock: 33,333 shares worth $67.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 5.2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Molecular Templates, Inc., an estimated $1.46M trimmed.

  • Monashee Investment Management's largest Q2 2020 buy was Nikola Corporation Common Stock: 33,333 shares worth $67.5M.
  • Monashee Investment Management added most to DermTech, Inc. Common Stock in Q2 2020, an estimated $930K increase.
  • Monashee Investment Management's biggest Q2 2020 reduction was Molecular Templates, Inc., cutting an estimated $1.46M.
  • Monashee Investment Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2020, selling an estimated $127M.
  • Monashee Investment Management's ten largest holdings make up 32% of its $669M portfolio in Q2 2020.
  • Monashee Investment Management opened 153 new positions and closed 16 in Q2 2020.
  • Monashee Investment Management's portfolio value rose 258% quarter-over-quarter to $669M.

Based on Monashee Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.